Mar 3, 2026 08:32AM
Mar 3, 2026 08:32AM
Mar 3, 2026 08:30AM
Mar 3, 2026 08:00AM
Feb 24, 2026 08:06AM
Feb 24, 2026 08:00AM
Feb 10, 2026 08:04AM Daxor transitions to Exchange Act reporting framework
Feb 10, 2026 08:00AM
Nov 25, 2025 08:00AM
Oct 21, 2025 08:00AM
Oct 15, 2025 08:00AM
Oct 15, 2025 08:00AM
Sep 30, 2025 08:00AM
Sep 23, 2025 08:04AM Daxor Corporation Unveils Next-Gen BVA Analyzer
Sep 23, 2025 08:00AM
Sep 4, 2025 08:00AM
Sep 4, 2025 08:00AM
Sep 3, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 08:00AM
Aug 7, 2025 07:58AM Daxor receives FDA clearance for rapid blood volume analyzer
Aug 7, 2025 07:55AM
Jul 22, 2025 08:00AM
May 14, 2025 08:00AM
May 13, 2025 08:00AM
May 13, 2025 08:00AM
May 7, 2025 08:00AM
May 6, 2025 08:00AM Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance
May 6, 2025 08:00AM
Apr 22, 2025 08:00AM
Apr 17, 2025 08:00AM
Apr 15, 2025 08:00AM
Apr 10, 2025 08:02AM
Apr 10, 2025 08:00AM
Apr 2, 2025 08:02AM Daxor Corp. (DXR) Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
Apr 2, 2025 08:00AM
Mar 28, 2025 08:00AM
Mar 4, 2025 04:55PM
Mar 4, 2025 03:53PM
Mar 4, 2025 08:06AM
Mar 4, 2025 08:05AM
Mar 4, 2025 08:00AM Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
Feb 28, 2025 08:00AM
Feb 27, 2025 08:00AM
Feb 19, 2025 08:03AM
Feb 19, 2025 08:00AM
Feb 18, 2025 08:00AM
Feb 18, 2025 08:00AM
Feb 14, 2025 08:00AM Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
Feb 14, 2025 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All